logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Dr Reddys Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500124
    INE089A01031
    291.7112166
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DRREDDY
    25.8
    106321.47
    EPS(TTM)
    Face Value()
    Div & Yield %:
    49.38
    1
    0.63
     
Date Headline
22-Oct-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
21-Oct-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Loss of Share Certificates
14-Oct-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Updates
14-Oct-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Loss of Share Certificates
08-Oct-2024 Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
08-Oct-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Press Release
05-Oct-2024 Dr Reddys announces incorporation of new step-down subsidiary in Denmark
30-Sep-2024 Dr Reddys acquires Haleon plc brands in NRT category
30-Sep-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Updates
26-Sep-2024 Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Other General Purpose
1 2 3 4 5  ...